Physiologically based pharmacokinetic models for systemic disposition of protein therapeutics in rabbits
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: 10.3389/fphar.2024.1427325
- Ereignis
-
Veröffentlichung
- (wo)
-
Aachen
- (wer)
-
Universitätsbibliothek der RWTH Aachen
- (wann)
-
2024
- Urheber
-
Jairam, Ravi Kumar
Franz, Maria
Hanke, Nina
Küpfer, Lars
- DOI
-
10.18154/RWTH-2025-01560
- URN
-
urn:nbn:de:101:1-2502220116540.940333640909
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:23 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Jairam, Ravi Kumar
- Franz, Maria
- Hanke, Nina
- Küpfer, Lars
- Universitätsbibliothek der RWTH Aachen
Entstanden
- 2024
Ähnliche Objekte (12)
Interspecies extrapolation by physiologically based pharmacokinetic modeling
Human physiologically based pharmacokinetic model for propofol
Ocular Physiologically Based Pharmacokinetic Modeling for Ointment Formulations
Highlight report: Interspecies extrapolation by physiologically based pharmacokinetic modeling
Adapting physiologically-based pharmacokinetic models for machine learning applications
Physiologically based pharmacokinetic modeling of intravenously administered nanoformulated substances
Application of a physiologically based pharmacokinetic model in predicting captopril disposition in children with chronic kidney disease
Physiologically based pharmacokinetic modeling of arterial – antecubital vein concentration difference
A minimal physiologically based pharmacokinetic model for high-dose methotrexate
In Vitro to In Vivo Extrapolation Linked to Physiologically Based Pharmacokinetic Models for Assessing the Brain Drug Disposition
Physiologically-based pharmacokinetic modelling for the prediction of adverse drug reactions
Human physiologically based pharmacokinetic model for ACE inhibitors: ramipril and ramiprilat
Interspecies extrapolation by physiologically based pharmacokinetic modeling
Human physiologically based pharmacokinetic model for propofol
Ocular Physiologically Based Pharmacokinetic Modeling for Ointment Formulations
Highlight report: Interspecies extrapolation by physiologically based pharmacokinetic modeling
Adapting physiologically-based pharmacokinetic models for machine learning applications
Physiologically based pharmacokinetic modeling of intravenously administered nanoformulated substances
Application of a physiologically based pharmacokinetic model in predicting captopril disposition in children with chronic kidney disease
Physiologically based pharmacokinetic modeling of arterial – antecubital vein concentration difference
A minimal physiologically based pharmacokinetic model for high-dose methotrexate
In Vitro to In Vivo Extrapolation Linked to Physiologically Based Pharmacokinetic Models for Assessing the Brain Drug Disposition
Physiologically-based pharmacokinetic modelling for the prediction of adverse drug reactions
Human physiologically based pharmacokinetic model for ACE inhibitors: ramipril and ramiprilat
Interspecies extrapolation by physiologically based pharmacokinetic modeling
Human physiologically based pharmacokinetic model for propofol
Ocular Physiologically Based Pharmacokinetic Modeling for Ointment Formulations
Highlight report: Interspecies extrapolation by physiologically based pharmacokinetic modeling
Adapting physiologically-based pharmacokinetic models for machine learning applications
Physiologically based pharmacokinetic modeling of intravenously administered nanoformulated substances
Application of a physiologically based pharmacokinetic model in predicting captopril disposition in children with chronic kidney disease
Physiologically based pharmacokinetic modeling of arterial – antecubital vein concentration difference
A minimal physiologically based pharmacokinetic model for high-dose methotrexate
In Vitro to In Vivo Extrapolation Linked to Physiologically Based Pharmacokinetic Models for Assessing the Brain Drug Disposition
Physiologically-based pharmacokinetic modelling for the prediction of adverse drug reactions